The global Medical Device Contract Development and Manufacturing Organization (CDMO) market was valued at USD 134.7 billion in 2025 and is projected to grow from USD 148.8 billion in 2026 to USD 352.6 billion by 2033, registering a CAGR of 13.1% from 2026 to 2033. North America dominated the market with a revenue share of 48.8% in 2025, reflecting the region’s strong medical technology ecosystem, advanced manufacturing capabilities, and established regulatory framework.

The market is experiencing substantial growth due to increasing outsourcing by original equipment manufacturers (OEMs), rising demand for advanced medical technologies, growing product complexity, and the need for specialized expertise in device design, development, validation, and large-scale manufacturing. As healthcare systems continue to evolve, medical device companies are increasingly partnering with CDMOs to accelerate innovation, improve operational efficiency, and reduce commercialization risks.

The growing prevalence of chronic diseases, aging populations, and rising demand for minimally invasive and home-based healthcare solutions are further creating opportunities for CDMOs that possess expertise in precision manufacturing, electronics integration, automation, and regulatory compliance.

Market Drivers and Dynamics

Rising Demand for Advanced Medical Devices

The growing adoption of technologically advanced medical devices is a major factor driving the expansion of the medical device CDMO market.

Download a free sample copy of the Medical Device Contract Development and Manufacturing Organization (CDMO) market report to understand detailed coverage and inclusions in the final report

Modern healthcare solutions increasingly incorporate:

• Connected diagnostic platforms
• AI-enabled medical systems
• Wearable health monitoring devices
• Implantable therapeutic devices
• Smart drug delivery systems
• Robotic-assisted surgical technologies
• Remote patient monitoring equipment

These sophisticated products require highly specialized manufacturing processes, advanced materials, miniaturized components, software integration, and strict regulatory compliance. Many OEMs choose to outsource these capabilities to CDMOs that offer end-to-end development and manufacturing expertise.

Additionally, investments in additive manufacturing, digital production technologies, and automated quality control systems are enabling CDMOs to support increasingly complex product requirements while maintaining regulatory standards and production scalability.

Growing Need for Specialized Expertise

One of the most significant drivers of market growth is the increasing need for multidisciplinary expertise.

Today's medical devices combine:

• Advanced biomaterials
• Embedded software systems
• Wireless connectivity
• Miniaturized electronics
• Precision engineering
• Cybersecurity frameworks
• Regulatory documentation requirements

Many small and mid-sized medical device companies lack the internal resources necessary to efficiently design, validate, and manufacture such complex products. By partnering with specialized CDMOs, OEMs gain access to experienced engineering teams, regulatory specialists, advanced manufacturing technologies, and global supply chain networks that help reduce development risks and accelerate time-to-market.

Looking for more specific insights? Customize this report to suite your business needs

Emerging Trend: Smart Manufacturing and Digital CDMOs

A key trend transforming the industry is the adoption of Industry 4.0 technologies. Leading CDMOs are implementing smart manufacturing platforms, AI-driven quality monitoring, digital twins, predictive maintenance systems, and automated production lines to improve efficiency, traceability, and compliance. These capabilities are becoming increasingly important as medical devices become more connected, data-driven, and technologically sophisticated.

Key Market Trends & Insights

Therapeutics Segment Leads Product Demand

• By product, the therapeutics segment accounted for 52.2% of market revenue in 2025.
• The segment includes high-value medical devices such as implants, infusion pumps, neurostimulators, cardiac rhythm management systems, and other advanced therapeutic technologies.
• Rising prevalence of chronic diseases and increasing demand for long-term disease management solutions continue to drive segment growth.
• The complexity and regulatory requirements associated with these products encourage OEMs to outsource manufacturing to experienced CDMOs.

Contract Manufacturing Dominates Service Segment

• By service, the contract manufacturing segment held the largest market share in 2025 and is projected to grow at the fastest CAGR during the forecast period.
• Services include component manufacturing, assembly manufacturing, accessories production, and complete device manufacturing.
• OEMs increasingly seek scalable, cost-effective, and compliant manufacturing solutions that allow them to focus resources on innovation and commercialization.

Class II Devices Hold the Largest Share

• By class, the Class II segment dominated the market in 2025.
• Devices such as infusion pumps, patient monitoring systems, imaging components, and electrosurgical equipment require precision engineering and stringent regulatory compliance.
• Growing demand for minimally invasive procedures, home healthcare technologies, and advanced diagnostic systems continues to support outsourcing activities in this category.

Cardiovascular Devices Lead by Application

• By application, the cardiovascular devices segment held the largest market share in 2025.
• Rising prevalence of cardiovascular diseases globally is increasing demand for advanced treatment solutions.
• Products such as stents, catheters, pacemakers, heart valves, defibrillators, and structural heart repair devices require highly specialized manufacturing processes and strict quality assurance.
• CDMOs play a critical role in helping manufacturers meet these complex production requirements.

OEMs Represent the Largest End-Use Segment

• By end use, the Original Equipment Manufacturers (OEMs) segment accounted for the largest market share in 2025 and is expected to witness the fastest growth during the forecast period.
• OEMs increasingly rely on CDMOs for design optimization, component sourcing, manufacturing scale-up, regulatory compliance, and supply chain management.
• Strategic outsourcing enables medical device companies to improve flexibility, reduce costs, and accelerate product launches.

Regional Highlights

North America Maintains Market Leadership

• North America accounted for 48.8% of global market revenue in 2025.
• The region benefits from a mature medical device industry, advanced healthcare infrastructure, strong regulatory frameworks, and a concentration of leading OEMs and CDMOs.
• Continued investments in medical technology innovation and digital healthcare solutions are supporting regional market growth.

United States Leads Global Demand

• The U.S. held the largest market share in 2025.
• Strong innovation ecosystems, extensive healthcare spending, and increasing outsourcing activities continue to drive demand for CDMO services across the country.

Asia Pacific Emerges as the Fastest-Growing Region

• Asia Pacific is expected to register the highest CAGR between 2026 and 2033.
• Expanding manufacturing capabilities, favorable production costs, growing healthcare investments, and increasing medical device demand are attracting both OEMs and CDMOs to the region.
• Countries such as China, India, South Korea, and Singapore are strengthening their positions as global medical device manufacturing hubs.

Explore Grand View Horizon to see global and regional level statistics related to the Medical Device Contract Development and Manufacturing Organization (CDMO) market  

Market Size & Forecast

• Market Size in 2025: USD 134.7 Billion
• Estimated Market Size in 2026: USD 148.8 Billion
• Projected Market Size by 2033: USD 352.6 Billion
• CAGR (2026–2033): 13.1%
• Largest Regional Market: North America
• Fastest-Growing Regional Market: Asia Pacific

Competitive Landscape

The medical device CDMO market is highly competitive, with leading companies focusing on strategic acquisitions, capacity expansion, service diversification, and technological innovation to strengthen their market positions.

Key competitive strategies include:

• Mergers and acquisitions
• Manufacturing facility expansion
• End-to-end service integration
• Advanced automation deployment
• Regulatory and compliance enhancement
• Strategic partnerships with OEMs
• Expansion into drug-device combination products

The increasing complexity of connected devices, implantable technologies, and minimally invasive solutions is encouraging deeper collaboration between OEMs and specialized CDMOs.

Industry Evolution Through Strategic Partnerships

The growing reliance on outsourcing is reflected in industry partnerships focused on accelerating product development and commercialization. Collaborations involving complex drug-device combination products, advanced therapeutic systems, and connected healthcare technologies demonstrate the expanding role of CDMOs across the medical device value chain.

Key Medical Device Contract Development and Manufacturing Organization Companies

The following companies have been profiled for this study on the medical device contract development and manufacturing organization market:

• Jabil Inc.
• Thermo Fisher Scientific Inc.
• Integer Holdings Corporation
• FLEX Ltd.
• Sanmina Corporation
• Celestica Inc.
• Phillips-Medisize
• Plexus Corp.
• Nipro Corporation
• Viant Technology LLC
• West Pharmaceutical Services, Inc.
• Mack Molding
• Cirtec Medical
• Cogmedix
• Synecco Ltd.
• TE Connectivity
• Keller Technology Corp.
• HDA Technology, Inc.

Conclusion

The global medical device contract development and manufacturing organization market is entering a period of sustained growth as medical device companies increasingly outsource development and manufacturing activities to address rising product complexity, regulatory requirements, and commercialization challenges. The convergence of advanced therapeutics, connected health technologies, minimally invasive procedures, and digital healthcare solutions is creating significant opportunities for specialized CDMOs worldwide.

As OEMs seek faster innovation cycles, scalable manufacturing capabilities, and access to specialized expertise, CDMOs are evolving into strategic partners that support the entire product lifecycle. With continued advancements in automation, additive manufacturing, smart quality systems, and digital manufacturing technologies, the medical device CDMO market is expected to play an increasingly critical role in shaping the future of global healthcare innovation through 2033.

Looking for a report customized to your requirements? Explore our Custom Research Offering

Grand View Research offers

• Focused market intelligence reports on specific geographies or high-growth segments
• Extended forecast timelines for long-term planning
• Competitor Benchmarking and Supply Chain Analysis
• Inclusion of regulatory and policy assessments
• Inclusion of custom data models, KPIs, or applications unique to your business
• Specific high-impact Data Decks and Tables to support effective decision making

And much more…